SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,502 | -24.7% | 80,260 | +0.9% | 0.00% | – |
| Q2 2023 | $369,721 | -52.1% | 79,510 | -52.4% | 0.00% | – |
| Q1 2023 | $772,224 | -84.7% | 167,148 | -73.2% | 0.00% | -100.0% |
| Q4 2022 | $5,044,619 | +21.8% | 624,334 | -16.4% | 0.00% | – |
| Q3 2022 | $4,143,000 | +19.7% | 746,455 | +12.3% | 0.00% | – |
| Q2 2022 | $3,462,000 | -42.9% | 664,411 | -9.9% | 0.00% | – |
| Q1 2022 | $6,064,000 | -44.7% | 737,681 | +0.1% | 0.00% | -100.0% |
| Q4 2021 | $10,971,000 | -21.2% | 737,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $13,928,000 | +1.6% | 737,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $13,706,000 | -18.3% | 737,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $16,781,000 | +42.3% | 737,300 | +35.8% | 0.00% | 0.0% |
| Q4 2020 | $11,789,000 | +246.4% | 543,000 | +60.4% | 0.00% | – |
| Q3 2020 | $3,403,000 | +354.3% | 338,600 | +250.9% | 0.00% | – |
| Q2 2020 | $749,000 | -23.8% | 96,500 | +0.1% | 0.00% | – |
| Q1 2020 | $983,000 | -43.7% | 96,403 | -39.3% | 0.00% | – |
| Q4 2019 | $1,746,000 | -13.7% | 158,700 | -28.7% | 0.00% | – |
| Q3 2019 | $2,023,000 | -36.0% | 222,600 | -19.8% | 0.00% | – |
| Q2 2019 | $3,159,000 | -30.7% | 277,572 | -30.6% | 0.00% | -100.0% |
| Q1 2019 | $4,556,000 | +26.2% | 400,000 | -0.1% | 0.00% | – |
| Q4 2018 | $3,611,000 | -39.8% | 400,350 | +0.1% | 0.00% | -100.0% |
| Q3 2018 | $6,000,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |